Clinical Trial: Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Brief Summary: The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.

Detailed Summary: The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.
Sponsor: Mayo Clinic

Current Primary Outcome: Survival status upon review of patients every 6 months [ Time Frame: 2 years ]

Original Primary Outcome: Survival status [ Time Frame: 2 years ]

Current Secondary Outcome: Progression free survival as evidenced by CT scan review [ Time Frame: 2 years ]

Original Secondary Outcome: Progression free survival [ Time Frame: 2 years ]

Information By: Mayo Clinic

Dates:
Date Received: November 20, 2015
Date Started: November 2015
Date Completion:
Last Updated: December 19, 2016
Last Verified: December 2016